If paradoxical bronchospasm occurs following dosing with YUPELRI, it should be treated immediately with an inhaled, short-acting bronchodilator. *This is not a guarantee of coverage. Do not increase your dose or use this medication more often than directed.Learn which of your inhalers/medications you should use every day and which you should use if your breathing suddenly worsens (quick-relief drugs).

Generic Yupelri Availability.

Keep all Do not flush medications down the toilet or pour them into a drain unless instructed to do so.

Terms and … YUPELRI should be discontinued immediately and alternative therapy should be instituted.YUPELRI should be used with caution in patients with narrow-angle glaucoma. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.In Canada - Call your doctor for medical advice about side effects. Yupelri is a brand name of revefenacin, approved by the FDA in the following formulation(s):. If You Are Uninsured You may qualify for the Mylan Patient Assistance Program.‡ If paradoxical bronchospasm occurs following dosing with YUPELRI, it should be treated immediately with an inhaled, short-acting bronchodilator. Yupelri will be approved based on all of the following criteria: a. Consult your Sorry. Find patient medical information for Yupelri Inhalation on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Site of care will determine coverage. Acute symptoms should be treated with an inhaled short-acting betaYUPELRI is contraindicated in patients with hypersensitivity to revefenacin or any component of this product.YUPELRI should not be initiated in patients during acutely deteriorating or potentially life-threatening episodes of COPD, or for the relief of acute symptoms, i.e., as rescue therapy for the treatment of acute episodes of bronchospasm. YUPELRI should be discontinued immediately and alternative therapy should be instituted.YUPELRI should be used with caution in patients with narrow-angle glaucoma.

Before using, check this product visually for particles or discoloration. Patient presents voucher/card to pharmacy for each refill: Limit: None: Re-application: New application every 12 months : Additional Information *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Medicare coverage and pricing details for Yupelri. If you notice other effects not listed above, contact your doctor or pharmacist.Call your doctor for medical advice about side effects.

Do not double the dose to catch up.Store at room temperature away from light and moisture. Please refer to CMS regulations and guidance and applicable MAC documentation requirements.When prescribing YUPELRI for patients new to nebulized therapy, include the following:Medicare requires a physician to document that a face-to-face evaluation with the patient, detailing the treatment and/or evaluation of a condition that supports the need for the nebulizer, occurred within the 6 months prior to the written order for a nebulizer.Remember to tell your commercially insured patients about theYUPELRI is contraindicated in patients with hypersensitivity to revefenacin or any component of this product.YUPELRI should not be initiated in patients during acutely deteriorating or potentially life-threatening episodes of COPD, or for the relief of acute symptoms, i.e., as rescue therapy for the treatment of acute episodes of bronchospasm. Yupelri was studied in one 52-week, open-label, active-control (tiotropium 18 mcg once daily) trial in 1,055 patients with COPD. Learn more about Medicare prescription drug plans and savings with GoodRx.